U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Luveltamab Tazide
INN   USAN  
Official Name English
SP-8166
Preferred Name English
LUVELTAMAB TAZIDE [USAN]
Common Name English
Immunoglobulin G1 [188,412-bis[4-(azidomethyl)-L-phenylalanine]], anti-(human folate receptor ?) (human-Mus musculus monoclonal SP8166 ?1-chain), disulfide with human-Mus musculus monoclonal SP8166 ?-chain, dimer
Common Name English
SP8166
Code English
luveltamab tazide [INN]
Common Name English
Code System Code Type Description
FDA UNII
KDY94MAQ0U
Created by admin on Wed Apr 02 02:02:10 GMT 2025 , Edited by admin on Wed Apr 02 02:02:10 GMT 2025
PRIMARY
CAS
2493327-59-4
Created by admin on Wed Apr 02 02:02:10 GMT 2025 , Edited by admin on Wed Apr 02 02:02:10 GMT 2025
PRIMARY
INN
12041
Created by admin on Wed Apr 02 02:02:10 GMT 2025 , Edited by admin on Wed Apr 02 02:02:10 GMT 2025
PRIMARY
NCI_THESAURUS
C188590
Created by admin on Wed Apr 02 02:02:10 GMT 2025 , Edited by admin on Wed Apr 02 02:02:10 GMT 2025
PRIMARY
USAN
LM-106
Created by admin on Wed Apr 02 02:02:10 GMT 2025 , Edited by admin on Wed Apr 02 02:02:10 GMT 2025
PRIMARY
SMS_ID
300000042077
Created by admin on Wed Apr 02 02:02:10 GMT 2025 , Edited by admin on Wed Apr 02 02:02:10 GMT 2025
PRIMARY
SUBSTANCE RECORD
Luveltamab Tazide
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966